ArticleJournal of thrombosis and thrombolysis2021

Evaluation of characteristics and dosing regimens in patients with new or recurrent thrombosis on apixaban and rivaroxaban.

Diane Dreucean et al.PubMed ↗Publisher ↗

No numbers read from the abstract.